After drug pricing tensions, industry pushes back at Trump's 'Buy American' order

Not long after President Donald Trump signed four executive orders focused on drug pricing, he last week laid out plans for a “Buy American” requirement for federal agencies purchasing essential medicines. As with the prior drug pricing proposals, industry pushback to the latest order was swift and harsh.

Under the new order, the federal government would develop a list of essential drugs, and then direct agencies such as the Department of Health and Human Services and Department of Veterans Affairs to purchase only from U.S. factories.